INS and Cognitive impairment: The beneficial outcomes of intranasal insulin in memory were proved to be attributed to improvement in the tau protein-to-Aβ42 ratio in cerebrospinal fluid, supporting future research to assess its clinical effectiveness for individuals with cognitive impairment over a longer period [111].